← Back to Clinical Trials
Recruiting NCT06676761
Outcomes of a Novel Technique Minimal Scar Mastectomy
Trial Parameters
Condition Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Sponsor KK Women's and Children's Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 100
Sex FEMALE
Min Age N/A
Max Age N/A
Start Date 2017-03-01
Completion 2030-12-31
Interventions
nipple sparing mastectomy without reconstruction
Brief Summary
Nipple sparing mastectomy is oncologically safe and has a good cosmetic outcome. However, nipple sparing mastectomy was conventionally performed with reconstruction. Minimal scar mastectomy (MSM) is a novel technique which could allow women, with non-ptotic breasts, who do not want reconstruction, to conserve their nipple areolar complex (NAC) and avoid the transverse scar associated with modified radical mastectomy. This is the first study on the oncologic and surgical outcomes of MSM.
Eligibility Criteria
Inclusion Criteria: breast cancer patients who opted for minimal scar mastectomy - Exclusion Criteria: breast cancer patients who underwent conventional mastectomy \-